Tag: Frost & Sullivan

Olink Earns Acclaim from Frost & Sullivan for its Cardiac Protein Biomarker Multiplex Panels, CVD II and CVD III

LONDON, Nov. 6, 2018 /PRNewswire/ — Based on its recent analysis of the global cardiac protein biomarker research market, Frost & Sullivan recognises Olink Proteomics with the 2018 Global Enabling Technology Leadership Award for developing its cardiovascular (CV) multiplex panels—CVD II and CVD III—featuring its proprietary Proximity Extension Assay (PEA) technology. The CVD II […]

PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for Its Proprietary DETOUR System for Percutaneous Bypass

LONDON, Aug. 31, 2017 /PRNewswire/ — Frost & Sullivan is pleased to recognize PQ Bypass with the 2017 European PAD Interventions Technology Innovation Award. PQ Bypass’ DETOUR System is a minimally invasive technology that enables physicians to re-direct, or detour, blood flow around extremely long blockages in the upper leg arteries to restore […]